Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « different »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
differences < different < differential  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 40.
[0-20] [0 - 20][0 - 40][20-40]
Ident.Authors (with country if any)Title
000000 (2020) Cheng Liu [République populaire de Chine] ; Xiaojun Guo [République populaire de Chine] ; Sunpeng Bai [République populaire de Chine] ; Guangjun Zeng [République populaire de Chine] ; Hao Wang [République populaire de Chine]lncRNA CASC2 downregulation participates in rheumatoid arthritis, and CASC2 overexpression promotes the apoptosis of fibroblast-like synoviocytes by downregulating IL-17
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000047 (2020) María Martín-L Pez [Espagne] ; Eliseo Albert [Espagne] ; Mario Fernández-Ruiz [Espagne] ; Isidoro González-Álvaro [Espagne] ; Esther Rodríguez [Espagne] ; José M. Aguado [Espagne] ; David Navarro [Espagne] ; José L. Pablos [Espagne]Torque teno virus viremia in patients with chronic arthritis: Influence of biologic therapies.
000091 (2020) Guillaume Decarriere [France] ; Thomas Barnetche [France] ; Bernard Combe [France] ; Cécile Gaujoux-Viala [France] ; Cédric Lukas [France] ; Jacques Morel [France] ; Claire Daien [France]The most appropriate conventional DMARD to combine with different advanced therapies in rheumatoid arthritis: a systematic literature review with meta-analysis.
000104 (2020) Wei Zhang [République populaire de Chine] ; Qiying Zhang [République populaire de Chine] ; Zihua Xuan [République populaire de Chine] ; Juan Liang [République populaire de Chine] ; Dongping Yang [République populaire de Chine] ; Meihuizi Ding [République populaire de Chine] ; Housheng Zhu [République populaire de Chine] ; Bo Su [République populaire de Chine] ; Xing Dai [République populaire de Chine] ; Xiaoyi Jia [République populaire de Chine]The Protective Effect of Different Polar Solvent Extracts of Er Miao San on Rats with Adjuvant Arthritis
000114 (2020) Pia M. Vidal [Chili] ; Rodrigo Pacheco [Chili]The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia
000144 (2020) Wolfgang F. Richter [Suisse] ; Hans-Peter Grimm [Suisse] ; Marie-Hélène Gouy [Suisse] ; Susi S Gaard [Danemark] ; Caroline Kreuzer [Suisse] ; Uwe Wessels [Allemagne] ; Dragomir Draganov [Suisse] ; Chris Muenzer [Suisse] ; Tonio Hoche [Suisse]Subcutaneous Site-of-Absorption Study with the Monoclonal Antibody Tocilizumab in Minipigs: Administration Behind Ear Translates Best to Humans.
000178 (2020) Adelaide Sofia Batalha Figueiredo [Portugal] ; Ana Luísa Oliveira [Portugal] ; Ant Nio Caetano [Portugal] ; Maria Francisca Moraes-Fontes [Portugal]SAPHO: has the time come for tailored therapy?
000183 (2020) Ibai Los-Arcos [Espagne] ; Juan Aguilar-Company [Espagne] ; Isabel Ruiz-Camps [Espagne]Risk of infection associated with new therapies for lymphoproliferative syndromes.
000204 (2020) Jennie H. Best [États-Unis] ; Steven C. Vlad [États-Unis] ; Lenore Tominna [États-Unis] ; Ibrahim Abbass [États-Unis]Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic.
000237 (2020) Zaid H. Temrikar [États-Unis] ; Satyendra Suryawanshi [États-Unis] ; Bernd Meibohm [États-Unis]Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients
000242 (2020) Colin H. Holtze [États-Unis] ; Elizabeth A. Freiheit [États-Unis] ; Susan L. Limb [États-Unis] ; John L. Stauffer [États-Unis] ; Karina Raimundo [États-Unis] ; Wayne T. Pan [États-Unis] ; Kevin R. Flaherty [États-Unis] ; Hyun J. Kim [États-Unis]Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry
000246 (2020) Christian Guder [Allemagne] ; Sascha Gravius [Allemagne] ; Christof Burger [Allemagne] ; Dieter C. Wirtz [Allemagne] ; Frank A. Schildberg [Allemagne]Osteoimmunology: A Current Update of the Interplay Between Bone and the Immune System
000277 (2020) Sergiu Pasca [Roumanie] ; Ancuta Jurj [Roumanie] ; Bobe Petrushev [Roumanie] ; Ciprian Tomuleasa [Roumanie] ; Daniela Matei [Roumanie]MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases
000280 (2020) Paramarjan Piranavan [États-Unis] ; Manjeet Bhamra [États-Unis] ; Andras Perl [États-Unis]Metabolic Targets for Treatment of Autoimmune Diseases
000305 (2020) Susanne H. C. Baumeister [États-Unis] ; Benedetta Rambaldi [États-Unis, Italie] ; Roman M. Shapiro [États-Unis] ; Rizwan Romee [États-Unis]Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation
000311 (2020) Durga Prasanna Misra [Inde] ; Sakir Ahmed [Inde] ; Vikas Agarwal [Inde]Is biological therapy in systemic sclerosis the answer?
000322 (2020) Rui Liu [République populaire de Chine] ; Bin Xu [République populaire de Chine] ; Shengqing Yu [République populaire de Chine] ; Jingfeng Zhang [République populaire de Chine] ; Huawei Sun [République populaire de Chine] ; Chuanmin Liu [République populaire de Chine] ; Fengying Lu [République populaire de Chine] ; Qunxing Pan [République populaire de Chine] ; Xiaofei Zhang [République populaire de Chine]Integrated Transcriptomic and Proteomic Analyses of the Interaction Between Chicken Synovial Fibroblasts and Mycoplasma synoviae
000334 (2020) Amin Gasmi [France] ; Sadaf Noor [Pakistan] ; Torsak Tippairote [Thaïlande] ; Maryam Dadar [Iran] ; Alain Menzel [France] ; Geir Bj Rklund [Norvège]Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
000344 (2020) Sadaf Atiqi [Pays-Bas] ; Femke Hooijberg [Pays-Bas] ; Floris C. Loeff [Pays-Bas] ; Theo Rispens [Pays-Bas] ; Gerrit J. Wolbink [Pays-Bas]Immunogenicity of TNF-Inhibitors
000361 (2020) Kunihiko Umekita ; Akihiko OkayamaHTLV-1 Infection and Rheumatic Diseases

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "different" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "different" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    different
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021